Glutathione-induced sodium currents in neocortex

NeuroReport

Volumn 7, Issue 6, 1996, Pages 1149-1152

  Shaw, Christopher A ^a   Pasqualotto, Bryce A ^a   Curry, Kenneth ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Precision Biochemicals Inc   (Canada)

Author keywords

Cortex; Cortical wedge; Excitatory amino acid receptors; Glutathione; Ionotropic receptors; Sodium currents

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTATHIONE; N METHYL DEXTRO ASPARTIC ACID; SODIUM ION;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN SLICE; DEPOLARIZATION; MEMBRANE POTENTIAL; NEOCORTEX; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT;

EID: 0029972067     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199604260-00010     Document Type: Article

References (40)

1. Meister A. In: Taniguichi N, Higashi T, Sakamoto Y et al (eds) Glutathione Centennial: Molecular Perspectives and Clinical Implications. San Diego: Academic Press, 1989: 31-11.
2. Kosower NS and Kosower EM. Int Rev Cytol 54, 109-160(1978).
3. Loomis WF. Ann NY Acad Sci 62, 209-228 (1955).
4. Lenhoff HM. J Gen Physiol 45, 331-344 (1961).
5. Bellis SL, Grosvenor W, Kass-Simon G et al. Biochim Biophys Acta 1061, 89-94 (1991).
6. Bellis SL, Kass Simon G and Rhoads DE. Biochemistry 31, 9838-9843 (1992).
7. Grosvenor W, Bellis SL, Kass-Simon G et al. Biochim Biophys Acta 1117, 120- 125 (1992).
8. Reichelt KL and Fonnum F. J Neurochem 16, 1409-1416 (1986).
9. Slivka A, Spina MB and Cohen G. Neurosci Lett 74, 112-118 (1987).
10. Raps SP, Lai JCK, Hertz L et al. Brain Res 493, 398-401 (1989).
11. Yudkoff M, Pleasure D, Cregar L et al. J Neurochem 55, 137-145 (1990).
12. Philbert MA, Beiswanger CM, Waters DK et al. Toxicol App. Pharmacol 107, 215-227 (1991).
13. Amara A, Coussemacq M and Geffard M. Brain Res 659, 237-242 (1994).
14. Pow DP and Crook DK. Neurosci Lett 193, 25-28 (1995)
15. Guo N and Shaw C. Mol Brain Res 15, 207-215 (1992).
16. Guo N, McIntosh C and Shaw C. Neuroscience 4, 835-842 (1992)
17. Ogita K, Kitago T, Nakamuta H et al. Life Sci 39, 2411-2418 (1986).
18. Ogita K and Yoneda Y. Neurosci Res 4, 486-496 (1987)
19. Ogita K and Yoneda Y. Brain Res 463, 37-46 (1988).
20. Ogita K and Yoneda Y. Biochem Pharmacol 38, 1499-1501 (1989).
21. Ogita K, Enomoto R, Nakahara F et al. J Neurochem 64, 1088-1096 (1995).
22. Pasqualotto BA and Shaw CA. Soc Neurosci Absfr 21, 1600 (1995).
23. Lanius RA, Shaw CA, Wagey R et al. J Neurochem 63, 155-160 (1994).
24. Bowlsby S and Shaw C. Soc Neurosci Abstr 17, 75 (1991).
25. Zangerle L, Cuenod M, Winterhalter KH and Do KQ. J Neurochem 59, 181-189 (1992).
26. Gilbert KR, Aizenman E and Reynolds IJ. Neurosci Lett 133, 11-14 (1991).
27. Sucher NJ and Lipton SA. J Neurosci Res 30, 582-591 (1991).
28. Leslie SW, Brown LM, Trent RD et al. Mol Pharmacol 41, 308-314 (1992).
29. Janaky R, Varga V, Saransaari P et al. Neurosci Lett 156, 153-157 (1993).
30. Kohr G, Eckardt S, Luddens H et al. Neuron 12, 1031-1040 (1994).
31. Pan Z-H, Bahring R, Grantyn R et al. J Neurosci 15, 1384-1391 (1995).
32. Berl S, Purpura DP, Giardo M et al. J Neurochem 4, 311-317 (1959).
33. Hiramatsu M and Mori A. Neurochem Res 6, 301-306 (1981).
34. Mitchell JD and Jackson MJ. In: Smith RA, ed. Handbook of Amyotrophic Lateral Sclerosis. Marcel Dekker: New York, 1992: 533-541.
35. Tohgi H, Abe T, Saheki M et al. Neurosci Lett 184, 21-24 (1994).
36. Lanius RA, Krieger C, Wagey R et al. Neurosci Lett 163, 89-92 (1993).
37. Harrison NL and Simmonds MA. Br J Pharmacol 84, 381-391 (1985).
38. Gozlan H and Ben-Ari Y. Trends Pharmacol Sci 16, 368-374 (1995).
39. Pace JR, Martin BM, Paul SM et al. Neurosci Lett 141, 97-100 (1992).
40. Thompson AM. Prog Neurobiol 35, 53-74 (1990).